Analyzing the atai Life Sciences IPO

English - June 10, 2021 01:00 - 50 minutes - 34.5 MB
Entrepreneurship Business Health & Fitness Mental Health psychedelics psychedelic psychedelic startups mental health wellness human flourishing Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Today's episode features three experts, Josh Hardman, Michael Haichin, and Graham Pechenik as they analyze atai’s S-1 in advance of their IPO.

In this episode, we discuss:

How atai went from idea to IPO in 3 yearsAn overview of atai’s drug development programs and enabling technologiesThe platform’s strategy and risks

Read the transcript here.
Watch episode 9 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh

Theme musi